Further investigation of morphine 3-glucuronide's role in the dose-limiting excitatory side-effects of morphine administered chronically to cancer patients (1998–1999)
- Grant type:
- Queensland Cancer Fund
- Researchers:
-
-
- Funded by:
- Queensland Cancer Fund
